COVID-19 convalescent plasma composition and immunological effects in severe patients

ABSTRACT: Convalescent plasma (CP) has emerged as a treatment for COVID-19. However, the composition and mechanism of action are not fully known. Therefore, we undertook a two-phase controlled study in which, first the immunological and metabolomic status of recovered and severe patients were evalua...

Full description

Autores:

Acosta Ampudia, Yeny
Monsalve, Diana M.
Rojas, Manuel
Rodríguez, Yhojan
Gallo, Juan Esteban
Salazar Uribe, Juan Carlos
Santander, María José
Cala, Mónica P.
Zapata Builes, Wildeman
Zapata, María Isabel
Manrique, Rubén
Pardo Oviedo, Juan Mauricio
Camacho, Bernardo
Ramírez Santana, Carolina
Anaya, Juan Manuel

Tipo de recurso:

Article of investigation

Fecha de publicación:

2021

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/28424

Acceso en línea:

http://hdl.handle.net/10495/28424

Palabra clave:

COVID-19
Cytokines
Citocinas
Autoantibodies
Autoanticuerpos
Immunization, Passive
Inmunización Pasiva

Rights

openAccess

License

http://creativecommons.org/licenses/by-nc-nd/2.5/co/